Sinco Pharmaceuticals Sets 28 Aug 2026 Board Meeting to Approve H1 Results and Mull Interim Dividend

Bulletin Express08-18

Sinco Pharmaceuticals Holdings Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the group’s interim results for the six months ended 30 June 2026 and decide whether to recommend an interim dividend.

The announcement, released on 18 August 2026 from Sichuan, specifies that the meeting will also authorise publication of the half-year financial statements once endorsed.

Board composition at the time of the notice is as follows: • Executive Directors: Chairman Huang Zhijian and Lei Shifeng • Non-executive Director: Jing Huan • Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong

No further financial details were disclosed in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150801733?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150801733","market":"hk","top_or_hot":-1,"title":"Sinco Pharmaceuticals Sets 28 Aug 2026 Board Meeting to Approve H1 Results and Mull Interim Dividend","media":"Bulletin Express","content":"<p>Sinco Pharmaceuticals Holdings Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the group’s interim results for the six months ended 30 June 2026 and decide whether to recommend an interim dividend.</p>\n<p>The announcement, released on 18 August 2026 from Sichuan, specifies that the meeting will also authorise publication of the half-year financial statements once endorsed.</p>\n<p>Board composition at the time of the notice is as follows:\n• Executive Directors: Chairman Huang Zhijian and Lei Shifeng  \n• Non-executive Director: Jing Huan  \n• Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong</p>\n<p>No further financial details were disclosed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinco Pharmaceuticals Sets 28 Aug 2026 Board Meeting to Approve H1 Results and Mull Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinco Pharmaceuticals Sets 28 Aug 2026 Board Meeting to Approve H1 Results and Mull Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinco Pharmaceuticals Holdings Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the group’s interim results for the six months ended 30 June 2026 and decide whether to recommend an interim dividend.</p>\n<p>The announcement, released on 18 August 2026 from Sichuan, specifies that the meeting will also authorise publication of the half-year financial statements once endorsed.</p>\n<p>Board composition at the time of the notice is as follows:\n• Executive Directors: Chairman Huang Zhijian and Lei Shifeng  \n• Non-executive Director: Jing Huan  \n• Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong</p>\n<p>No further financial details were disclosed in the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06833","symbol_name":"兴科蓉医药","start_time":0,"source_url":"","article_id":"1150801733","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150801733","pubTimestamp":1787042753,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinco Pharmaceuticals Holdings Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the group’s interim results for the six months ended 30 June 2026...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06833":"兴科蓉医药"},"translate_title":"Sinco Pharmaceuticals 定于 2026 年 8 月 28 日召开董事会会议，批准上半年业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06833":1},"content_text":"Sinco Pharmaceuticals Holdings Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the group’s interim results for the six months ended 30 June 2026 and decide whether to recommend an interim dividend.\nThe announcement, released on 18 August 2026 from Sichuan, specifies that the meeting will also authorise publication of the half-year financial statements once endorsed.\nBoard composition at the time of the notice is as follows:\n• Executive Directors: Chairman Huang Zhijian and Lei Shifeng  \n• Non-executive Director: Jing Huan  \n• Independent Non-executive Directors: Lau Ying Kit, Wang Qing, Liu Wenfang and Bai Zhizhong\nNo further financial details were disclosed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150801733","isCrawlerRequest":true}